Search Results for keywords:"drug enforcement"

Found 3 results
Skip to main content

Search Results: keywords:"drug enforcement"

  • Type:Notice
    Citation:86 FR 2456
    Reading Time:about a minute or two

    Medi-Physics, Inc., which does business as GE Healthcare, has submitted an application to the Drug Enforcement Administration (DEA) to become an importer of specific controlled substances. The company intends to import small amounts of Ioflupane, which is an analogue of Cocaine, for research and development purposes, as the required form is unavailable in the U.S. Anyone wishing to comment or request a hearing on this application must do so by February 11, 2021. The DEA's approval will depend on compliance with specific regulatory standards.

    Simple Explanation

    Medi-Physics, Inc., also known as GE Healthcare, wants to bring a special kind of medicine ingredient, related to Cocaine, from outside the U.S. because they can't get it here. They need it to work on how to make and check their products properly, and people can share their thoughts or concerns about this until February 11, 2021.

  • Type:Notice
    Citation:90 FR 13886
    Reading Time:about 2 minutes

    The Drug Enforcement Administration (DEA) has announced that Royal Beverages, LLC has applied to become a registered bulk manufacturer of marijuana, which is a Schedule I controlled substance. This registration would allow Royal Beverages, LLC, located in Harrisburg, Pennsylvania, to produce bulk active pharmaceutical ingredients (APIs) for research purposes. Comments or objections about this application can be submitted electronically through the Federal eRulemaking Portal before May 27, 2025. The DEA will evaluate the application based on certain legal regulations to ensure it complies with all laws and safeguards against illegal distribution.

    Simple Explanation

    The big U.S. agency called the DEA is thinking about letting a company named Royal Beverages in Pennsylvania make lots of marijuana for scientist studies.

  • Type:Notice
    Citation:90 FR 13885
    Reading Time:about 6 minutes

    The Drug Enforcement Administration (DEA) is revoking the registration of Dr. Harvey Leslie, which allowed him to handle controlled substances. This is because his medical license in Georgia has been revoked, and he can no longer practice medicine or legally handle controlled substances there. Since having a valid state license is necessary to maintain DEA registration for handling controlled substances, Dr. Leslie's registration is being revoked, effective April 28, 2025. The decision was signed by the Acting Administrator, Derek Maltz, on March 20, 2025.

    Simple Explanation

    Dr. Harvey Leslie can't give out certain medicines anymore because the people in charge took away his permission to be a doctor in Georgia, and without that, he can't have the special approval to handle these medicines.